Why Innovation Activity Rarely Reaches the P&L

Why activity is not innovation ROI

Most companies disappointed by their innovation ROI are not short of innovation activity; they are funding activity that was never connected to an operating result, and measuring it in a way that cannot tell the difference. Innovation ROI is the measurable financial and operational return from what the work actually changed: revenue from commercialised launches, margin from redesigned processes, capacity released in constrained operations, or capital expenditure avoided. Ideas submitted, hackathons hosted, post-it walls filled and prototypes demonstrated are inputs and intermediate steps, not returns.

The gap between strategic ambition and operational readiness is wide across global surveys, even allowing for self-reported data. In BCG’s 2024 survey of more than 1,000 senior innovation executives, 83% of companies ranked innovation among their top three priorities, yet only 3% met BCG’s threshold for readiness to deliver on it. An earlier McKinsey Global Innovation Survey exhibit (reported by Christensen, Hall, Dillon and Duncan in Harvard Business Review, September 2016) showed a similar split: 84% of executives stated that innovation was important to their growth strategy, while only 6% reported being satisfied with their organisation’s innovation performance. Neither survey is an audit of financial accounts, and both reflect executive perception, yet across a decade of polling the pattern has barely moved.

Why capable teams produce innovation theatre

When innovation spend fails to move the P&L, the fault is rarely in the talent or effort of the team; capable people placed inside a system that measures visible activity will reliably supply visible activity. Under board or market pressure to show momentum, senior leaders ask for tangible signs that the organisation is modernising, and the innovation function delivers exactly what is inspected: launch events, incubator cohorts, vendor showcases and full project pipelines.

Steve Blank calls this pattern innovation theatre: the workshops happen, the stage gates are populated, the quarterly slides are accurate, and what is performed is the appearance of progress rather than the retirement of commercial or operational risk. When leadership grows frustrated after two years and replaces the head of innovation — or swaps one training vendor for another — while leaving the reporting metrics and budget handoffs untouched, the new team reproduces the same theatre within twelve months. An underperforming innovation function is almost always evidence about the management system around it.

Four places where translation to the P&L breaks

Activity stops short of the accounts at four specific joints in the management system, each of which sits outside the authority of an innovation team to fix on its own.

1. Measures reward volume of activity rather than risk retired.When the reporting line to the executive committee tracks ideas generated, workshops delivered and pilots launched, rational managers optimise for project count. Nobody is rewarded for proving early and cheaply that an attractive assumption is false.
2. No rule connects strategic priorities to funding decisions.Strategy documents name broad themes — digitalisation, sustainability, adjacent growth — without stating the boundary conditions that disqualify a proposal. In PwC’s 2017 Innovation Benchmark of 1,200 executives, 54% reported struggling to align innovation strategy with business strategy, and strategic alignment — not R&D budget size — was the strongest predictor of performance.
3. Validation has no pre-agreed handoff into an operating budget.A pilot is funded out of a central innovation envelope, proves its concept in a sandbox, and then arrives at a business unit whose annual capital and headcount budgets were locked eight months earlier. Because the operating unit did not co-design the constraint or reserve capacity to absorb it, the validated pilot sits in an unowned gap between “proven in a test” and “funded in production.”
4. Nothing routinely stops underperforming work.Stopping is the weakest muscle in corporate governance. In PwC’s 2026 Global CEO Survey of 4,454 chief executives across 95 countries, only one in four (25%) said their organisation had rigorous, routine processes to terminate underperforming R&D and innovation projects. Where nothing is stopped, capital and engineering attention remain trapped in legacy commitments nobody actively chose to keep.

What changes when the CEO reopens the question: three cases

Measurement belongs to finance, portfolio selection belongs to strategy, and delivery capacity belongs to operations; the innovation team holds none of those levers. Only a chief executive or business-unit P&L owner whose authority spans all three functions can connect them. When leadership shifts the question from “What innovation activities are we running?” to “Which operational constraint is holding back our target result, and what must change in the work?”, the economics move without waiting for speculative technology.

1. Rethinking a retail store-opening sequence (Client-projected).Our client, a convenience-store operator running a continuous rollout programme across Thailand, needed several months to open each new store (Case 01). Because a store earns nothing until the day it trades, every week of cycle time tied up committed capital. Design approvals, sign-offs and construction each looked efficient when measured inside their own function, so the usual fix was to ask each department to work faster. Examining the cycle end to end with the client team showed the delay sat in an inherited serial sequence: steps waited on each other by habit rather than physical necessity. Holding cost and quality fixed, the client’s project team projected that the redesigned sequence could reduce total opening cycle time by approximately 67% if fully implemented — stated as the client team’s feasibility projection, not a measured result.
2. Inspecting automotive plastics before colouring (Client-implemented, with client model).Our client, an automotive plastic-injection manufacturer, inspected finished parts at the end of its production line (Case 06). Once a plastic part is coloured, however, it cannot be recycled; every defect caught at the end of the line became permanent waste. Walking the line with the client, Bold Group noticed that almost all defects were already visible before colouring, and proposed adding a second inspection station immediately ahead of the colouring step so rejected pieces could return directly to the melt. The client designed, staffed and runs the station. Physical plastic waste dropped toward zero, and the client’s accounting department modelled an approximate 75% reduction in the annual accounting cost of waste (50% from colouring cost avoided plus 25% from raw-material buy-back).
3. Cancelling a warehouse expansion and reshaping thermal demand (Client decision / Mechanism).At a manufacturing client with a growing order backlog (Case 07), production was blamed and a larger warehouse was planned. Tracing the flow showed procurement buyers, measured solely on unit price, were buying volume-discount lots beyond the production plan, filling the warehouse and blocking needed materials. Linking storage cost to procurement’s metric resolved the bottleneck, and the CEO cancelled the planned warehouse expansion. At a food manufacturer we worked with, cold-storage energy consumption had been treated as a fixed building cost; re-planning the production schedule changed the shape of the demand instead, without new refrigeration hardware.

What this looks like in Thailand

Thai business is not short of private R&D and innovation spending. In WIPO’s Global Innovation Index 2025, Thailand ranked first in the world for the share of national R&D financed by business enterprises (80.8%), while ranking 90th globally for knowledge-intensive employment; Thailand placed 45th of 139 economies overall in 2025 and 44th in the 2026 edition. Figures from Thailand’s National Research Council (NRCT) show gross domestic expenditure on R&D reaching 0.94% of GDP in 2023, two-thirds of it funded by companies.

The money is already being spent. In our work with Thai conglomerates and listed groups, the leakage between that corporate spend and the P&L usually happens in two places. First, innovation or digital subsidiaries run pilot programmes under separate memorandums of understanding, while core operating companies lock their annual budgets on a strict fiscal calendar with no mechanism to absorb mid-year validated changes. Second, in committee cultures that prize harmony and seniority, stopping an initiative sponsored by a senior executive is read as a personal criticism rather than a routine portfolio reallocation — so low-return projects are kept alive on maintenance budgets for years.

Where to start on Monday

You do not need a reorganisation to test whether your measurement and funding system is the constraint. Run three checks with finance, strategy and operations in the same room:

1. Ask for next month’s innovation report in commercial and operational units.Replace ideas submitted, workshops held and active pilots with four numbers: revenue from launches in the last 24 months, capacity or cycle time released by redesigned processes, capital or operating cost avoided, and resources recovered by stopping projects early.
2. Require a named operating receiver before funding any pilot past discovery.Before a project receives build funding, require the business-unit or functional owner who will run it in production to sign off on the operational baseline, the target threshold, and the budget line that will carry it if the test succeeds.
3. Install a blameless stopping rule at every funding gate.Define in advance the specific assumption test or threshold that will trigger termination, and record money saved by stopping invalidated projects as a positive governance outcome rather than a team failure.

Where this does not apply

Where a product genuinely does not work technically, where customer demand does not exist at a viable price, or where an organisation lacks a specialist scientific or engineering discipline it has never operated, the problem is technical or commercial rather than structural. Redesigning governance and measurement will make that reality visible much faster, which is valuable, but it will not substitute for building the underlying technical capability.